Literature DB >> 15377349

Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions.

S Boulinguez1, C Grison-Tabone, L Lamant, S Valmary, R Viraben, J M Bonnetblanc, C Bédane.   

Abstract

BACKGROUND: It has been proposed that the management of incompletely excised recurrent basal cell carcinomas (BCCs) should depend on their histological appearance, and that nonaggressive recurrent BCCs may not require re-excision.
OBJECTIVES: To determine the histological evolution of recurrent BCCs.
METHODS: In a 14-year retrospective study analysing histological sections of recurrent BCCs, 390 specimens from 191 patients were blindly classified by three physicians into aggressive and nonaggressive types according to Sexton's classification. Initial histological sections were available for 33 of the recurrent BCCs. Descriptive analysis was performed.
RESULTS: Eight of 33 (24%) recurrent BCCs became histologically more aggressive. Four of 20 (20%) originally nonaggressive BCCs became aggressive during recurrence and four of 13 (31%) originally aggressive BCCs showed a more aggressive component during recurrence. These incompletely excised aggressive BCCs were sited in periorbital and perinasal areas and on the cheek, and were re-excised.
CONCLUSIONS: Management of incompletely excised nonaggressive BCCs (nodular or superficial types) is still a matter of debate. Previously reported studies have shown recurrence in < 10% of nonaggressive incompletely excised BCCs. Our study showed that rare recurrences of these initially nonaggressive BCCs showed an aggressive component in 20% of cases. These results suggest that initially nonaggressive incompletely excised BCCs do not require re-excision except if they are located in sites with a poor prognosis.

Entities:  

Mesh:

Year:  2004        PMID: 15377349     DOI: 10.1111/j.1365-2133.2004.06135.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  13 in total

1.  Clinical usefulness of high-frequency ultrasonography in the monitoring of basal cell carcinoma treatment effects.

Authors:  Magdalena Raszewska-Famielec; Adam Borzêcki; Dorota Krasowska; Grażyna Chodorowska
Journal:  Postepy Dermatol Alergol       Date:  2020-07-16       Impact factor: 1.837

2.  Treatment of facial Basal cell carcinoma: a review.

Authors:  Vanessa Smith; Shernaz Walton
Journal:  J Skin Cancer       Date:  2011-04-27

3.  Correlation of Global MicroRNA Expression With Basal Cell Carcinoma Subtype.

Authors:  Christopher Heffelfinger; Zhengqing Ouyang; Anna Engberg; David J Leffell; Allison M Hanlon; Patricia B Gordon; Wei Zheng; Hongyu Zhao; Michael P Snyder; Allen E Bale
Journal:  G3 (Bethesda)       Date:  2012-02-01       Impact factor: 3.154

Review 4.  Surgical treatment of basal cell carcinoma: an algorithm based on the literature.

Authors:  Flávio Barbosa Luz; Camila Ferron; Gilberto Perez Cardoso
Journal:  An Bras Dermatol       Date:  2015-06-01       Impact factor: 1.896

Review 5.  [Basal cell basal cell epithelioma of the face: surgical management, about 45 cases and review of the literature].

Authors:  Mohamed Amine Ennouhi; Abdenacer Moussaoui
Journal:  Pan Afr Med J       Date:  2014-09-25

6.  Clinicopathological analysis of recurrent basal cell carcinoma of the eyelid.

Authors:  Aleksandra Iljin; Tomasz Zieliński; Bogusław Antoszewski; Stanisław Sporny
Journal:  Postepy Dermatol Alergol       Date:  2016-02-29       Impact factor: 1.837

7.  Incomplete excision of basal cell carcinoma (BCC) in the head and neck region: to wait, or not to wait?

Authors:  Jakub Miszczyk; Michał Charytonowicz; Tomasz Dębski; Bartłomiej Noszczyk
Journal:  Postepy Dermatol Alergol       Date:  2017-12-31       Impact factor: 1.837

8.  Recurrence rate of basal cell carcinoma with positive histopathological margins and related risk factors.

Authors:  Fernanda Lara; Jesus Rodriguez Santamaría; Luiz Eduardo Fabricio de Melo Garbers
Journal:  An Bras Dermatol       Date:  2017 Jan-Feb       Impact factor: 1.896

9.  Chronicle of a pigmented superficial Basal cell carcinoma.

Authors:  Marie Caucanas; Claudine Piérard-Franchimont; Gérald E Piérard
Journal:  Case Rep Dermatol Med       Date:  2012-07-08

Review 10.  Management of high-risk and advanced basal cell carcinoma.

Authors:  S Puig; A Berrocal
Journal:  Clin Transl Oncol       Date:  2015-02-03       Impact factor: 3.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.